Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?

PURPOSE: Despite evidence supporting at least five years of endocrine therapy for early breast cancer, many women discontinue therapy early. We investigated the impact of initial therapy type and specific comorbidities on discontinuation of endocrine therapy in clinical practice. METHODS: We identif...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kemp, Anna, Preen, David B, Saunders, Christobel, Boyle, Frances, Bulsara, Max, Malacova, Eva, Roughead, Elizabeth E
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2014
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4058005/
https://ncbi.nlm.nih.gov/pubmed/24936397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-3-282
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky